May 2004
585
m), 4.15 (2H, t, Jꢀ4.8 Hz), 4.59 (2H, s), 6.86 (1H, d, Jꢀ8.8 Hz), 6.97 (2H,
d, Jꢀ8.8 Hz), 7.26—7.68 (7H, m), 7.82—7.91 (3H, m).
Jꢀ5.0 Hz), 6.88 (1H, d, Jꢀ8.0 Hz), 6.98 (2H, d, Jꢀ8.8 Hz), 7.39—7.51 (4H,
m), 7.85 (1H, s). Anal. Calcd for C28H35NO4: C, 74.80; H, 7.85; N, 3.12.
Methyl 7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(thiazol-2-yl)methyl]-2,3- Found: C, 74.51; H, 7.92; N, 2.98.
dihydro-1H-1-benzazepine-4-carboxylate (14l) Yield 88%. 1H-NMR
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-cyclohexylmethyl-2,3-dihydro-1H-
(CDCl3) d 0.93 (3H, t, Jꢀ7.2 Hz), 1.34—1.45 (2H, m), 1.57—1.70 (2H, m), 1-benzazepine-4-carboxylic Acid (7i) Yield 89%, mp 124—125 °C. 1H-
2.87 (2H, t, Jꢀ4.4 Hz), 3.42 (2H, t, Jꢀ4.4 Hz), 3.55 (2H, t, Jꢀ6.6 Hz),
3.78—3.82 (5H, m), 4.16 (2H, t, Jꢀ5.6 Hz), 4.86 (2H, s), 6.95—7.00 (3H, Jꢀ6.6 Hz), 3.32 (2H, t-like), 3.56 (2H, t, Jꢀ6.6 Hz), 3.81 (2H, d, Jꢀ5.0 Hz),
m), 7.30 (1H, d, Jꢀ3.2 Hz), 7.40 (1H, dd, Jꢀ8.4, 2.2 Hz), 7.46 (2H, d, 4.16 (2H, t, Jꢀ5.0 Hz), 6.89 (1H, d, Jꢀ8.8 Hz), 6.98 (2H, d, Jꢀ8.8 Hz),
NMR (CDCl3) d 0.90—1.85 (18H, m), 2.83 (3H, t-like), 3.22 (2H, d,
Jꢀ8.6 Hz), 7.56 (1H, d, Jꢀ2.6 Hz), 7.78—7.81 (2H, m).
7.39—7.53 (4H, m), 7.88 (1H, s). Anal. Calcd for C30H39NO4: C, 75.44; H,
8.23; N, 2.93. Found: C, 75.46; H, 8.23; N, 2.96.
Methyl
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(1-methyl-1H-imidazol-2-
yl)methyl]-2,3-dihydro-1H-1-benzazepine-4-carboxylate (14m) Yield
59%. 1H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.2 Hz), 1.38—1.45 (2H, m),
1.54—1.65 (2H, m), 2.41 (2H, t, Jꢀ4.7 Hz), 3.30 (2H, t, Jꢀ4.7 Hz), 3.51
(3H, s), 3.56 (2H, t, Jꢀ6.2 Hz), 3.79—3.83 (5H, m), 4.17 (2H, t, Jꢀ4.4 Hz),
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-phenyl-2,3-dihydro-1H-1-benz-
azepine-4-carboxylic Acid (7j) Yield 75%, mp 129—131 °C. 1H-NMR
(CDCl3) d 0.94 (3H, t, Jꢀ7.2 Hz), 1.34—1.49 (2H, m), 1.55—1.69 (2H, m),
2.86 (2H, t, Jꢀ4.4 Hz), 3.56 (2H, t, Jꢀ6.6 Hz), 3.79—3.84 (4H, m), 4.17
4.61 (2H, s), 6.88 (1H, d, Jꢀ1.0 Hz), 6.97—7.06 (4H, m), 7.44—7.50 (3H, (2H, t, Jꢀ4.8 Hz), 6.90—7.04 (5H, m), 7.17 (1H, d, Jꢀ8.6 Hz), 7.23—7.31
m), 7.56 (1H, d, Jꢀ2.2 Hz), 7.77 (1H, s).
Methyl 7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(1-methyl-1H-pyrazol-5-yl)
methyl]-2,3-dihydro-1H-1-benzazepine-4-carboxylate (14n) Yield 67%.
1H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.4 Hz), 1.34—1.45 (2H, m), 1.55—
1.70 (2H, m), 2.58 (2H, t, Jꢀ4.8 Hz), 3.27 (2H, t, Jꢀ4.8 Hz), 3.56 (2H, t,
(2H, m), 7.40 (1H, dd, Jꢀ8.6, 2.0 Hz), 7.50 (2H, d, Jꢀ7.2 Hz), 7.64 (1H, d,
Jꢀ2.0 Hz), 7.90 (1H, s). Anal. Calcd for C29H31NO4: C, 76.12; H, 6.83; N,
3.06. Found: C, 76.18; H, 6.85; N, 3.21.
-
1-Benzyl-7-{4-[2-(butoxy)ethoxy]phenyl}-2,3-dihydro-1H-1-benz-
azepine-4-carboxylic Acid (7k) Yield 89%, mp 133—138 °C. 1H-NMR
Jꢀ7.0 Hz), 3.79—3.83 (8H, m), 4.17 (2H, t, Jꢀ4.4 Hz), 4.52 (2H, s), 6.22 (CDCl3) d 0.93 (3H, t, Jꢀ7.4 Hz), 1.34—1.45 (2H, m), 1.54—1.65 (2H, m),
(1H, d, Jꢀ1.8 Hz), 6.92 (1H, d, Jꢀ8.8 Hz), 6.99 (2H, d, Jꢀ8.8 Hz), 7.40— 2.80 (2H, br), 3.34 (2H, br), 3.56 (2H, t, Jꢀ6.6 Hz), 3.80 (2H, t, Jꢀ5.0 Hz),
7.50 (4H, m), 7.57 (1H, d, Jꢀ2.2 Hz), 7.79 (1H, s).
4.16 (2H, t, Jꢀ5.0 Hz), 4.61 (2H, s), 6.88 (1H, d, Jꢀ8.8 Hz), 6.98 (2H, d,
Jꢀ8.8 Hz), 7.26—7.49 (8H, m), 7.57 (1H, d, Jꢀ2.2 Hz), 7.94 (1H, s). Anal.
Calcd for C30H33NO4: C, 76.41; H, 7.05; N, 2.97. Found: C, 76.06; H, 7.15;
Methyl 7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(1-methyl-1H-pyrazol-4-yl)-
methyl]-2,3-dihydro-1H-1-benzazepine-4-carboxylate (14o) Yield 63%.
1H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.4 Hz), 1.34—1.45 (2H, m), 1.50— N, 2.68.
1.70 (2H, m), 2.76 (2H, t, Jꢀ5.0 Hz), 3.27 (2H, t, Jꢀ5.0 Hz), 3.56 (2H, t,
Jꢀ7.0 Hz), 3.78—3.83 (5H, m), 3.89 (3H, s), 4.16 (2H, t, Jꢀ5.2 Hz), 4.42
(2H, s), 6.92—7.00 (3H, d), 7.29 (1H, s), 7.40 (1H, dd, Jꢀ8.4, 2.0 Hz),
7.45—7.49 (3H, m), 7.54 (1H, d, Jꢀ2.0 Hz), 7.78 (1H, s).
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(thiazol-2-yl)methyl]-2,3-dihydro-
1H-1-benzazepine-4-carboxylic Acid (7l) Yield 78%, mp 105—107 °C.
1H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.6 Hz), 1.34—1.45 (2H, m), 1.54—
1.65 (2H, m), 2.89 (2H, br), 3.45 (2H, br), 3.55 (2H, t, Jꢀ6.6 Hz), 3.80 (2H,
t, Jꢀ5.0 Hz), 4.16 (2H, t, Jꢀ5.0 Hz), 4.88 (2H, s), 6.96—7.01 (3H, m), 7.31
(1H, d, Jꢀ3.3 Hz), 7.46—7.49 (3H, m), 7.57 (1H, d, Jꢀ2.6 Hz), 7.80 (1H, d,
Jꢀ3.3 Hz), 7.91(1H, s). Anal. Calcd for C27H30N2O4S: C, 67.76; H, 6.32; N,
5.85. Found: C, 67.76; H, 6.39; N, 5.70.
Methyl 7-{4-[2-(Butoxy)ethoxy]phenyl}-1-phenyl-2,3-dihydro-1H-1-
benzazepine-4-carboxylate (14j) To
a
solution of 22 (500 mg,
1.26 mmol), copper(II) pivalate (70 mg, 0.26 mmol) in CH2Cl2 was added
triphenylbismuth diacetate (780 mg, 1.40 mmol) at room temperature. After
being stirred at room temperature over night, the reaction mixture was
poured into 3 N HCl. The mixture was neutralized using 1 N NaOH, and ex-
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(1-methyl-1H-imidazol-2-yl)-
methyl]-2,3-dihydro-1H-1-benzazepine-4-carboxylic Acid (7m) Yield
tracted with EtOAc. The organic layer was washed with water and brine, 80%. 1H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.4 Hz), 1.30—1.50 (2H, m),
dried over MgSO4, and concentrated in vacuo. The residue was purified by
1.54—1.70 (2H, m), 2.47 (2H, br), 3.32 (2H, br), 3.54—3.59 (5H, m), 3.80
column chromatography (hexane : EtOAc) to give 0.42 g (71%) of 14j as yel- (2H, t, Jꢀ4.9 Hz), 4.16 (2H, t, Jꢀ4.9 Hz), 4.68 (2H, s), 6.88 (1H, s), 6.98
low crystals, mp 80—82 °C. 1H-NMR (CDCl3) d 0.94 (3H, t, Jꢀ7.1 Hz),
1.31—1.49 (2H, m), 1.56—1.69 (2H, m), 2.85 (2H, t, Jꢀ4.4 Hz), 3.56 (2H,
t, Jꢀ6.6 Hz), 3.79—3.84 (7H, m), 4.17 (2H, t, Jꢀ4.9 Hz), 6.87—7.02 (5H,
(2H, d, Jꢀ8.4 Hz), 7.03—7.07 (2H, m), 7.45—7.49 (3H, m), 7.57 (1H, d,
Jꢀ2.2 Hz), 7.85 (1H, s).
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(1-methyl-1H-pyrazol-5-yl)-
m), 7.16—7.30 (3H, m), 7.40 (1H, dd, Jꢀ8.8, 2.2 Hz), 7.51 (2H, d, methyl]-2,3-dihydro-1H-1-benzazepine-4-carboxylic Acid (7n) Yield
1
Jꢀ8.4 Hz), 7.64 (1H, d, Jꢀ2.2 Hz), 7.80 (1H, s). Anal. Calcd for 77%, mp 145—148 °C. H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.0 Hz), 1.34—
C30H33NO4: C, 76.41; H, 7.05; N, 2.97. Found: C, 76.30; H, 7.17; N, 2.90.
7-{4-[2-(Butoxy)etoxy]phenyl}-1-isobutyl-2,3-dihydro-1H-1-benz-
azepine-4-carboxylic Acid (7f) To a solution of 14f (750 mg, 1.66 mmol)
in THF (15 ml) and MeOH (15 ml) was added 1 N NaOH (7.5 ml, 7.5 mmol)
at room temperature. After being stirred at room temperature for 20 h, the
reaction mixture was acidified using 1 N HCl under ice cooling. The mixture
1.45 (2H, m), 1.55—1.65 (2H, m), 2.62 (2H, br s), 3.30 (2H, br s), 3.56 (2H,
t, Jꢀ7.0 Hz), 3.79—3.84 (5H, m), 4.17 (2H, t, Jꢀ5.0 Hz), 4.54 (2H, s), 6.22
(1H, d, Jꢀ1.8 Hz), 6.93 (1H, d, Jꢀ8.8 Hz), 6.99 (2H, d, Jꢀ8.8 Hz), 7.43—
7.50 (4H, m), 7.58 (1H, d, Jꢀ2.2 Hz), 7.89 (1H, s). Anal. Calcd for
C28H33N3O4: C, 70.71; H, 6.99; N, 8.84. Found: C, 70.48; H, 6.90; N, 8.80.
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-[(1-methyl-1H-pyrazol-4-yl)-
was extracted with EtOAc. The organic layer was washed with brine, dried methyl]-2,3-dihydro-1H-1-benzazepine-4-carboxylic Acid (7o) Yield
1
over MgSO4, and concentrated in vacuo. The precipitated crystals were col-
69%, mp 131—133 °C. H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.4 Hz), 1.34—
1.49 (2H, m), 1.55—1.65 (2H, m), 2.79 (2H, t, Jꢀ4.2 Hz), 3.30 (2H, t,
Jꢀ4.2 Hz), 3.56 (2H, t, Jꢀ6.6 Hz), 3.81 (2H, t, Jꢀ4.8 Hz), 3.90 (3H, s),
lected by filtration, washed with hexane : EtOAc (6 : 1) to give 610 mg (84%)
1
of 7f as yellow crystals. H-NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.0 Hz), 0.96
(6H, d, Jꢀ6.6 Hz), 1.34—1.47 (2H, m), 1.54—1.66 (2H, m), 1.96—2.18 4.16 (2H, t, Jꢀ5.2 Hz), 4.44 (2H, s), 6.94—7.01 (3H, m), 7.30 (1H, s),
(1H, m), 2.79—2.85 (2H, m), 3.19 (2H, d, Jꢀ6.8 Hz), 3.30—3.35 (2H, m),
3.56 (2H, t, Jꢀ6.6 Hz), 3.81 (2H, t, Jꢀ4.8 Hz), 4.16 (2H, t, Jꢀ4.8 Hz), 6.90
(1H, d, Jꢀ8.8 Hz), 6.98 (2H, d, Jꢀ8.8 Hz), 7.38—7.53 (4H, m), 7.89 (1H,
s).
The following compounds (7g—o) were prepared from the corresponding
esters (14g—o) by a method similar to that described for 7f.
7.40—7.50 (4H, m), 7.56 (1H, d, Jꢀ2.0 Hz), 7.90 (1H, s). Anal. Calcd for
C28H33N3O4: C, 70.71; H, 6.99; N, 8.84. Found: C, 70.52; H, 6.90; N, 8.70.
Methyl 1-(tert-Butoxycarbonyl)-7-(4-morpholinophenyl)-2,3-dihydro-
1H-1-benzazepine-4-carboxylate (23) This compound was prepared in
82% yield from 20 by a method similar to that described for 14a, mp 183—
185 °C. 1H-NMR (CDCl3) d 1.49 (9H, s), 2.90 (2H, t, Jꢀ5.0 Hz), 3.19—
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-cyclopropylmethyl-2,3-dihydro-1H- 3.24 (4H, m), 3.69 (2H, t, Jꢀ5.0 Hz), 3.83 (3H, s), 3.87—3.91 (4H, m), 6.98
1
1-benzazepine-4-carboxylic Acid (7g) Yield 96%, mp 152—155 °C. H- (2H, d, Jꢀ9.0 Hz), 7.48 (2H, m), 7.52 (2H, d, Jꢀ9.0 Hz), 7.58 (1H, s), 7.73
NMR (CDCl3) d 0.25—0.33 (2H, m), 0.59—0.68 (2H, m), 0.93 (3H, t, (1H, s). Anal. Calcd for C27H32N2O5: C, 69.81; H, 6.94; N, 6.03. Found: C,
Jꢀ7.3 Hz), 1.05—1.20 (1H, m), 1.30—1.49 (2H, m), 1.55—1.69 (2H, m), 69.57; H, 6.76; N, 5.76.
2.87 (2H, t, Jꢀ4.6 Hz), 3.25 (2H, d, Jꢀ6.4 Hz), 3.42 (2H, t, Jꢀ4.6 Hz), 3.56
Methyl 7-(4-Morpholinophenyl)-2,3-dihydro-1H-1-benzazepine-4-car-
(2H, t, Jꢀ6.6 Hz), 3.81 (2H, t, Jꢀ5.0 Hz), 4.16 (2H, t, Jꢀ5.0 Hz), 6.93— boxylate (24) This compound was prepared in 93% yield from 23 by a
7.00 (3H, m), 7.40—7.54 (4H, m), 7.89 (1H, s). Anal. Calcd for C27H33NO4: method similar to that described for 21, mp 175—182 °C. 1H-NMR (CDCl3)
C, 74.45; H, 7.64; N, 3.22. Found: C, 74.27; H, 7.45; N, 3.21.
7-{4-[2-(Butoxy)ethoxy]phenyl}-1-cyclobutylmethyl-2,3-dihydro-1H-1-
d 2.89 (2H, t, Jꢀ4.5 Hz), 3.17—3.22 (4H, m), 3.41 (2H, t, Jꢀ4.5 Hz), 3.81
(3H, s), 3.87—3.91 (4H, m), 6.67 (1H, d, Jꢀ8.3 Hz), 6.97 (2H, d,
benzazepine-4-carboxylic Acid (7h) Yield 87%, mp 110—112 °C. 1H- Jꢀ8.8 Hz), 7.33 (1H, dd, Jꢀ8.3, 2.0 Hz), 7.45—7.50 (3H, m), 7.73 (1H, s).
NMR (CDCl3) d 0.93 (3H, t, Jꢀ7.3 Hz), 1.30—2.00 (8H, m), 2.00—2.15 Anal. Calcd for C22H24N2O3·0.2H2O: C, 71.80; H, 6.68; N, 7.61. Found: C,
(2H, m), 2.71—2.80 (3H, m), 3.29 (2H, t, Jꢀ4.8 Hz), 3.39 (2H, d, 71.51; H, 6.72; N, 7.47.
Jꢀ7.0 Hz), 3.55 (2H, t, Jꢀ6.6 Hz), 3.80 (2H, d, Jꢀ5.0 Hz), 4.16 (2H, t,
Methyl 1-Acetyl-7-(4-morpholinophenyl)-2,3-dihydro-1H-1-benzaze-